FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.3  |  FHIR Version n/a  User: [n/a]

385114002: Prolonged-release transdermal patch (dose form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3634738017 Prolonged-release transdermal patch (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3634739013 Prolonged-release transdermal patch en Synonym Active Entire term case insensitive SNOMED CT core module
106069801000001110 Transdermal patch en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom Edition module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prolonged-release transdermal patch Is a Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Is a Drug patch false Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form intended site Transdermal true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Is a Transdermal dose form true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form administration method Apply true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form transformation No transformation true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form release characteristic Prolonged-release true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has basic dose form Patch true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Bupramyl 20micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Bupramyl 20micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Bupramyl 5micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Bupramyl 10micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Bupramyl 20micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 50micrograms/24hours / Levonorgestrel 20micrograms/24hours patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 50micrograms/24hours / Levonorgestrel 7micrograms/24hours patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 50micrograms/24hours / Levonorgestrel 10micrograms/24hours patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Glyceryl trinitrate 15mg/24hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Glyceryl trinitrate 5mg/24hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Glyceryl trinitrate 10mg/24hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Hyoscine hydrobromide 1mg/72hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotine 7mg/24hours patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotine 14mg/24hours patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotine 21mg/24hours patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotine 5mg/16hours patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotine 10mg/16hours patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotine 15mg/16hours patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 80micrograms patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 37.5micrograms patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 40micrograms patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 75micrograms patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 25micrograms patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 50micrograms patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 100micrograms patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Testosterone 2.5mg/24hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Testosterone 5mg/24hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Testosterone 6mg/24hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 25micrograms/hour patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 50micrograms/hour patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 75micrograms/hour patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 100micrograms/hour patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Norethisterone 170micrograms/24hours / Estradiol 50micrograms/24hours patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Norethisterone 250micrograms/24hours / Estradiol 50micrograms/24hours patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 35micrograms/hour transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 52.5micrograms/hour transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 70micrograms/hour transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rotigotine 4mg/24hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rotigotine 6mg/24hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rotigotine 2mg/24hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Granisetron 3.1mg/24hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Busiete 5micrograms/hour transdermal patches (Teva UK Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Busiete 5micrograms/hour transdermal patches (Teva UK Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Busiete 10micrograms/hour transdermal patches (Teva UK Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Busiete 10micrograms/hour transdermal patches (Teva UK Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Busiete 20micrograms/hour transdermal patches (Teva UK Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Busiete 20micrograms/hour transdermal patches (Teva UK Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Busiete 5micrograms/hour transdermal patches (Teva UK Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Busiete 10micrograms/hour transdermal patches (Teva UK Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Busiete 20micrograms/hour transdermal patches (Teva UK Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Turgeon 35micrograms/hour transdermal patches (Teva UK Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Turgeon 35micrograms/hour transdermal patches (Teva UK Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Turgeon 52.5micrograms/hour transdermal patches (Teva UK Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Turgeon 52.5micrograms/hour transdermal patches (Teva UK Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Turgeon 70micrograms/hour transdermal patches (Teva UK Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Turgeon 70micrograms/hour transdermal patches (Teva UK Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Turgeon 35micrograms/hour transdermal patches (Teva UK Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Turgeon 52.5micrograms/hour transdermal patches (Teva UK Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Turgeon 70micrograms/hour transdermal patches (Teva UK Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Opiodur 12micrograms/hour transdermal patches (RX Farma) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Opiodur 12micrograms/hour transdermal patches (RX Farma) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Opiodur 25micrograms/hour transdermal patches (RX Farma) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Opiodur 25micrograms/hour transdermal patches (RX Farma) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Opiodur 50micrograms/hour transdermal patches (RX Farma) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Opiodur 50micrograms/hour transdermal patches (RX Farma) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Opiodur 75micrograms/hour transdermal patches (RX Farma) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Opiodur 75micrograms/hour transdermal patches (RX Farma) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Opiodur 100micrograms/hour transdermal patches (RX Farma) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Opiodur 100micrograms/hour transdermal patches (RX Farma) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Opiodur 12micrograms/hour transdermal patches (RX Farma) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Opiodur 25micrograms/hour transdermal patches (RX Farma) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Opiodur 50micrograms/hour transdermal patches (RX Farma) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Opiodur 75micrograms/hour transdermal patches (RX Farma) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Opiodur 100micrograms/hour transdermal patches (RX Farma) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Carlosafine 35micrograms/hour transdermal patches (Glenmark Pharmaceuticals Europe Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Carlosafine 35micrograms/hour transdermal patches (Glenmark Pharmaceuticals Europe Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Carlosafine 52.5micrograms/hour transdermal patches (Glenmark Pharmaceuticals Europe Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Carlosafine 52.5micrograms/hour transdermal patches (Glenmark Pharmaceuticals Europe Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Carlosafine 70micrograms/hour transdermal patches (Glenmark Pharmaceuticals Europe Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Carlosafine 70micrograms/hour transdermal patches (Glenmark Pharmaceuticals Europe Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Bunov 5micrograms/hour transdermal patches (Glenmark Pharmaceuticals Europe Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Bunov 5micrograms/hour transdermal patches (Glenmark Pharmaceuticals Europe Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Bunov 10micrograms/hour transdermal patches (Glenmark Pharmaceuticals Europe Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Bunov 10micrograms/hour transdermal patches (Glenmark Pharmaceuticals Europe Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Bunov 20micrograms/hour transdermal patches (Glenmark Pharmaceuticals Europe Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Bunov 20micrograms/hour transdermal patches (Glenmark Pharmaceuticals Europe Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Carlosafine 35micrograms/hour transdermal patches (Glenmark Pharmaceuticals Europe Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Carlosafine 52.5micrograms/hour transdermal patches (Glenmark Pharmaceuticals Europe Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Carlosafine 70micrograms/hour transdermal patches (Glenmark Pharmaceuticals Europe Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Bunov 5micrograms/hour transdermal patches (Glenmark Pharmaceuticals Europe Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Bunov 10micrograms/hour transdermal patches (Glenmark Pharmaceuticals Europe Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Bunov 20micrograms/hour transdermal patches (Glenmark Pharmaceuticals Europe Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 25micrograms/hour transdermal patches Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 50micrograms/hour transdermal patches Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 75micrograms/hour transdermal patches Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 100micrograms/hour transdermal patches Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 50micrograms/24hours / Norethisterone 170micrograms/24hours transdermal patches Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 50micrograms/24hours / Norethisterone 250micrograms/24hours transdermal patches Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 35micrograms/hour transdermal patches Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 52.5micrograms/hour transdermal patches Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 70micrograms/hour transdermal patches Has dispensed dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier

Start Previous Page 20 of 21 End

This concept is not in any reference sets

Back to Start